Jillian M. Schurr

Katten Muchin Rosenman LLP

General

Experience8 yrs

Elite Ratings

--

Practice Areas

Reexam/Aband. (2 cases)

Chemical (2 cases)

Biotech (35 cases)

Law Firms

Katten Muchin Rosenman LLP (Current)

jillian.schurr@katten.com

Ratings

Experience

Grade

Trend

DCT

L3

E

PTAB

--

--

--

CAFC

--

--

--

Cases

Case #	Court	Caption	Filed	Represent
3:26-CV-04811	D. NJ	Opus Genetics Inc v. Sandoz Inc	04/29/26	Patent Owner :Famygen Life Sciences Inc	.
2:25-CV-02580	D. NJ	Aurinia Pharma Inc v. Hikma Pharma USA Inc	04/10/25	Challenger :Hikma Pharmaceuticals USA Inc	.
1:25-CV-00024	N.D. WV	Salix Pharma Inc v. Mylan Pharma Inc	03/26/25	Challenger :Mylan Pharmaceuticals Inc	.
3:25-CV-01895	D. NJ	Opus Genetics Inc v. Sandoz Inc	03/14/25	Patent Owner :Famygen Life Sciences Inc	.
1:24-CV-00726	D. DE	Veloxis Pharma Inc v. Sun Pharmaceutical Industries Ltd	06/19/24	Challenger :Sun Pharmaceutical Industries Ltd	.
1:24-CV-00621	D. DE	Pfizer Inc v. Apotex Inc	05/23/24	Challenger :Apotex Corp	.
1:23-CV-00759	D. DE	Mitsubishi Tanabe Pharma Corp v. Cipla USA Inc	07/12/23	Challenger :Apotex Corp	.
2:22-CV-00216	D. VT	UCB Inc v. Mylan Tech Inc	12/12/22	Challenger :Mylan Technologies Inc	.
1:22-CV-01423	D. DE	AbbVie Inc v. Alkem Laboratories Ltd	10/27/22	Challenger :Lupin Ltd	.
1:22-CV-01365	D. DE	Merck KGaA v. Hopewell Pharma Ventures Inc	10/17/22	Challenger(W) :Apotex Inc	.

Ratings Trends

Practice Areas